Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 3/20 | 0.34 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | CNR1 | P21554 | 5/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
| ▸ | PPARD | Q03181 | 1/20 | 0.31 |
| ▸ | PPARA | Q07869 | 1/20 | 0.31 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7345976 | 0.80 | FAAH (0.40) | CNR2KCNK3ALDH1A1THRBBLM | |
| SCHEMBL7345972 | 0.80 | FAAH (0.40) | CNR2KCNK3ALDH1A1THRBBLM | |
| SCHEMBL27998395 | 0.73 | PPARG (0.36) | CNR2KCNK3ALDH1A1THRBBLM | |
| SCHEMBL26928708 | 0.72 | TSHR (0.42) | CNR2KCNK3ALDH1A1THRBBLM | |
| SCHEMBL5052433 | 0.72 | SMN1; SMN2 (0.33) | ALDH1A1 | |
| SCHEMBL3432184 | 0.72 | CNR1 (0.38) | BLMCNR1PPARGPPARDPPARA | |
| SCHEMBL7965431 | 0.72 | — | — | |
| SCHEMBL1202989 | 0.72 | — | — | |
| SCHEMBL5597055 | 0.72 | CNR1 (0.38) | BLMCNR1PPARGPPARDPPARA | |
| SCHEMBL1202992 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2661428-B1 | QUINOXALINES AND AZA-QUINOXALINES AS CRTH2 RECEPTOR MODULATORS | MERCK SHARP & DOHME (US) | 2017-06-07 | — | — | EP | disclosed |